Anika Therapeutics | ANIK - Dividendenrendite

Aktienkurs
15.28
Täglich Wechseln
-0.02 -0.13%
Monatlich
6.41%
Jährlich
13.44%
Q2 Prognose
14.36




Dy Veränderung Datum
Abbott 1.92 0.15 2025-12
Agenus 0 0 2025-03
Anika Therapeutics 0 0 2025-03
Enanta Pharmaceuticals 0 0 2025-03
Heron Therapeutics 0 0 2025-03
Intrexon 0 0 2025-03
J&J 2.16 0.34 2026-03
Karyopharm Therapeutics 0 0 2025-03
Rigel Pharmaceuticals 0 0 2025-03
Sangamo BioSciences 0 0 2025-03
Sanofi 4.74 0.25 2025-12
Smith & Nephew USD 2.44 0.66 2025-12
Stryker 0.97 0.06 2025-12
Surmodics 0 0 2025-03
Zimmer Biomet Holdings 1.07 0.09 2025-12